Ryman Healthcare stock fell 4 percent to NZD 1.68 on October 8, 2026

Published on 10/08/2026 at 08:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Ryman Healthcare stock posted NZD 855.6 million in fiscal 2026 revenue, while its net loss narrowed to NZD 171.3 million. The NZX quote reached NZD 1.68 on October 8, 2026.

RYM, NZRYME0001S4, Illustration mit AI erstellt.

Ryman Healthcare stock (ISIN NZRYME0001S4) fell 4 percent to NZD 1.68 on the NZX at 5:00 p.m. NZDT on October 8, 2026. The move puts the share at its 52-week low of NZD 1.68 and gives the company a market capitalization of NZD 1.7 billion.

Fiscal 2026 revenue reached NZD 855.6 million

Simply Wall St reported that Ryman Healthcare generated NZD 855.6 million in revenue for fiscal 2026, up 13 percent from NZD 760.7 million in fiscal 2025. The same fiscal-year data show a net loss of NZD 171.3 million, compared with a NZD 436.8 million loss in fiscal 2025.

The earnings comparison is substantial, but the company remained loss-making in fiscal 2026. Earnings per share improved to a NZD 0.17 loss from a NZD 0.61 loss in fiscal 2025, which makes the loss reduction more visible than the revenue increase alone.

Price pressure deepened across several periods

Interest.co.nz reported on October 8, 2026, that Ryman Healthcare was down 3 percent during the session, extending its five-day decline to 6 percent and its one-month decline to 16 percent. The report also placed the six-month decline at 22 percent and the year-on-year decline at 40 percent.

The market figures show how sharply the share price has diverged from the latest revenue trend. Revenue increased 13 percent in fiscal 2026, while the October 8 quote stood 44.9 percent below the 52-week high of NZD 3.05.

Retirement villages remain the core business

Ryman Healthcare operates integrated retirement villages and aged care facilities in New Zealand and Australia, combining independent living, assisted living and aged care. On its investor centre, the company describes its model as a continuum of care within its retirement communities.

For investors, the key tension is visible in the numbers: fiscal 2026 revenue reached NZD 855.6 million, yet the company still reported a NZD 171.3 million net loss. The stock's NZD 1.68 level therefore reflects a market that is weighing revenue growth against the pace of a return to profitability.

Ryman Healthcare stock reaches its yearly low

Ryman Healthcare stock was last at NZD 1.68 on the NZX at 5:00 p.m. NZDT on October 8, 2026, down 4 percent from the NZD 1.75 prior close. The session volume was 1,398,165 shares, while the 52-week range was NZD 1.68 to NZD 3.05.